Huatai Zijin
华泰紫金
elsewhere's corpus doesn't carry a dedicated profile of Huatai Zijin — no material covering its founding, size, or strategy — so we can't give a proper "what it is" answer from our sources. What the corpus does show is Huatai Zijin appearing on the investor side of deals covered by partner institutions: it followed on into GenAns Tech's (健达九州) several-hundred-million-RMB Series A as an existing shareholder through one of its funds, per a Gaorong Venture piece , and it participated in Spirit AI's rounds — co-investing in the ~600M RMB Pre-A+ in 2025 and re-upping in the near-2-billion-yuan round at a 10B+ valuation in early 2026, as reported by Oasis Capital . On that evidence it reads as an active institutional investor across healthcare and AI, but anything more specific isn't in our coverage.
AI-generated — may contain errors, please verify.
Coverage
Gaorong Ventures Report: Physical AI, Domestic Computing Power, Controllable Nuclear Fusion, and Medical Innovation Companies Close Major Funding Rounds
From the continuous leap in model capabilities to hard tech crossing the thresholds of engineering and industrialization, a new wave of technological innovation is accelerating toward the real world.
Jianda Jiuzhou Closes Hundreds of Millions of RMB in Series A Funding, Cementing Global Leadership in Precision Therapies for Brain Science and Ophthalmology
Accelerating the market launch of precision therapies for brain diseases.
Spirit AI Closes Nearly 2 Billion Yuan Funding Round! Valuation Exceeds 10 Billion Yuan | Oasis Capital Vitality
Accelerating Machines' Understanding of the Physical World
"White Rhino" Closes New Funding Round with SF Holding's Third Investment in a Year, Total Series B Nears 500 Million RMB | Linear Portfolio
Accelerate the scaled deployment of White Rhino in last-mile logistics.
Spirit AI Closes Nearly 600 Million RMB Pre-A+ Round | Oasis Vitality
Consultant Vitality
